It’s a battle between Ugrappa and Shantha in Ballari

Bengaluru, Jul 16: Aiming to forge a citizen-government partnership in combating the Covid pandemic, the Karnataka government is seeking plasma donations from survivors for a token appreciation of Rs 5,000, a minister said on Wednesday.

"I request all those who have recovered from Covid-19 to donate plasma and save lives. As a token of our appreciation, we will give Rs 5,000 to patients who come forward and donate their plasma," said Medical Education Minister K. Sudhakar.

He said the battle against the pandemic can only be won through citizen-government partnership.

On Wednesday, Covid cases swelled by 1,975 infections in Bengaluru, ground zero for the pandemic in the southern state, raising its total number of cases to 22,944, out of which 17,051 are active.

In the past 24 hours, the state as a whole registered a record 3,176 cases, raising Karnataka's tally to 47,253, even as 87 people succumbed to the virus.

Meanwhile, Sudhakar said 8,134 booth level workforce will conduct a house to house survey along with other Covid control measures in Bengaluru.

He said many locals and block level officers will be the members of the workforce.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Chikkamagaluru, Jul 22: Nine staff of the Anti Naxal Force (ANF) in Koppa in the district were tested positive for Covid-19 on Wednesday.

Health officials said that these people don’t have any contacts outside as they were in the forest buffer zone. Now efforts were being made to find out how they contacted the Coronavirus.

Meanwhile, the Kalsa police station has been sealed down after four of its personnel tested positive.